HB Investment

Founded in 1999, HB Investment is a venture capital firm headquartered in Seoul, South Korea. It invests in small and medium-sized businesses with growth potential across various sectors, including technology, healthcare, entertainment, and semiconductor industries. The company provides consulting services to support the growth of its portfolio companies.

Park Ha-jin

CEO

Past deals in South Korea

MakinaRocks

Funding Round in 2024
MakinaRocks is a global AI software startup founded in 2017 and headquartered in Seoul, South Korea. The company specializes in developing enterprise solutions that leverage machine intelligence to address industry-specific challenges. Its platform focuses on analytics and performance management, offering tools for predictive maintenance, operational optimization, and anomaly detection. By combining advanced artificial intelligence model development with practical applications, MakinaRocks enables businesses to enhance productivity and operational efficiency through cost-effective automation and intelligent control.

Onheal

Series B in 2023
Onheal is a company based in South Korea that specializes in the veterinary sector, focusing on the development and distribution of medicines and medical devices for companion animals. The company operates a healthcare platform aimed at extending the life of pets, offering a range of animal medicines and equipment. Through veterinary research and efficacy tests, Onheal provides essential products that support the health and well-being of companion animals, enabling pet owners to access functional and healthy food options for their dogs and other pets.

EnhancedBio

Series C in 2022
EnhancedBio Inc. is a biopharmaceutical company based in Seoul, South Korea, that focuses on researching and developing anti-cancer therapeutics. Founded in 2016, the company is dedicated to creating innovative treatments for cancer patients globally. Its product pipeline includes HPV siRNA therapeutics aimed at addressing various cancers linked to Human Papilloma Virus infection. In addition, EnhancedBio is developing small molecular drug candidates targeting other oncological pathways, such as PTEN, PMVK, and RRM2. By concentrating on target-specific drugs and companion diagnostics, EnhancedBio aims to enhance cancer treatment options available to healthcare professionals, ultimately improving patient outcomes.

Bbodek

Series B in 2022
Bbodek is a Seoul-based company that provides tableware rental and washing services for restaurants and school cafeterias in Korea. It offers children's tableware and hygiene management products and operates a self-developed smart factory to deliver high-quality services, enabling clients to focus on cooking without cleanup. It is expanding into customized washing machine manufacturing and sales.

Novelty Nobility

Series B in 2022
Novelty Nobility is a biotechnology company specializing in the research and development of antibody-based therapeutics targeting novel angiogenesis factors. The company focuses on ophthalmology and oncology, aiming to address unmet medical needs through innovative treatments.

Novelty Nobility

Series B in 2021
Novelty Nobility is a biotechnology company specializing in the research and development of antibody-based therapeutics targeting novel angiogenesis factors. The company focuses on ophthalmology and oncology, aiming to address unmet medical needs through innovative treatments.

MakinaRocks

Series A in 2020
MakinaRocks is a global AI software startup founded in 2017 and headquartered in Seoul, South Korea. The company specializes in developing enterprise solutions that leverage machine intelligence to address industry-specific challenges. Its platform focuses on analytics and performance management, offering tools for predictive maintenance, operational optimization, and anomaly detection. By combining advanced artificial intelligence model development with practical applications, MakinaRocks enables businesses to enhance productivity and operational efficiency through cost-effective automation and intelligent control.

Odd Concepts

Series B in 2020
Odd Concepts Inc. is a technology company specializing in computer vision and artificial intelligence solutions. Founded in 2012 and based in Seoul, South Korea, it offers a comprehensive portfolio of image recognition and search technologies delivered as a cloud-based API service. The company's innovative platform is designed to meet diverse customer needs by allowing for the tuning and combination of analysis engines to achieve optimal results. Additionally, Odd Concepts develops software for video content searches, facilitating connections between offline retail businesses and online markets. This enables clients to conduct product data analysis and provide personalized product recommendations, enhancing the overall shopping experience.

Laseroptek

Venture Round in 2020
Laseroptek Co. Ltd. is a global developer and manufacturer of advanced laser equipment tailored for medical and industrial applications. Founded in 2000 and based in Seonnam-si, South Korea, the company specializes in various laser systems, including the Picolo for treating pigmented lesions, tattoo removal, scar correction, and skin rejuvenation. It also offers the Pallas, an ultraviolet laser system aimed at addressing complex skin conditions such as vitiligo and psoriasis. Other notable products include the Helios and Lotus series, the Zelos alexandrite laser system, and the Hyperion, a long pulsed laser system recognized for its stability and effectiveness.

Dabeeo

Series A in 2019
Dabeeo Inc. is an AI technology company based in Seoul, South Korea, founded in 2012. Specializing in geospatial data, Dabeeo focuses on creating a digital twin of the Earth by utilizing AI-powered data transformation to digitize spatial information. The company offers a comprehensive mapping technology platform that enables users to manage spatial data effectively. By employing artificial intelligence and deep learning, Dabeeo provides quick access to live maps and locations, allowing for open-source map editing. This innovation enhances the quality of map data available to businesses, improving productivity and convenience across various industries.

HonestFund

Series B in 2019
HonestFund Co., LTD. is a financial technology company based in Seoul, South Korea, founded in 2015. It operates an online financial platform that provides access to a diverse array of investment opportunities, including residential and commercial real estate, infrastructure financing, unsecured personal loans, and various bond investment products. The platform is designed to facilitate a transparent and efficient process for both investors and private issuers, thereby attracting significant investments from prominent financial institutions. HonestFund's unique offering allows individuals and institutional investors to engage in alternative investments, enhancing their portfolio diversification and access to capital.

Crowdworks

Series B in 2019
CrowdWorks, Inc. is a South Korea-based company that operates an online crowdsourcing platform specifically designed for artificial intelligence (AI). The company focuses on enhancing machine learning processes by collecting, structuring, and strengthening training data. It provides services that include the analysis and classification of various types of data, such as images, text, audio, and survey responses. By utilizing a pool of approximately 500,000 qualified labelers, CrowdWorks aims to improve the accuracy of human-powered data, thereby streamlining the AI model training workflow. The platform's Auto-ML features facilitate efficient data preparation, making it an essential resource for over 430 leading AI companies seeking to rapidly develop and deploy advanced AI solutions.

HonestFund

Series B in 2018
HonestFund Co., LTD. is a financial technology company based in Seoul, South Korea, founded in 2015. It operates an online financial platform that provides access to a diverse array of investment opportunities, including residential and commercial real estate, infrastructure financing, unsecured personal loans, and various bond investment products. The platform is designed to facilitate a transparent and efficient process for both investors and private issuers, thereby attracting significant investments from prominent financial institutions. HonestFund's unique offering allows individuals and institutional investors to engage in alternative investments, enhancing their portfolio diversification and access to capital.

Vuno

Series B in 2018
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.

BBB Technologies

Series B in 2018
BBB Technologies Inc. is a mobile healthcare technology company focused on blood-based diagnostics and data-driven insights to support early disease detection, treatment decisions, and remote monitoring for patients and clinicians. Founded in 2014 and based in Mountain View, California, with offices in Seoul and Shenzhen, it develops blood testing technologies and mobile-enabled tools that deliver rapid results and actionable insights. The company leverages artificial intelligence to analyze blood biomarkers and enable at-home testing and remote patient monitoring, aiming to broaden access to diagnostics across multiple conditions.

Birdview

Series B in 2018
BirdView Inc. is a South Korean company that specializes in developing and providing an internet-based mobile application focused on cosmetics. The company offers a platform named HwaHae, which is available on both iOS and Android devices. This application enables users to access detailed reviews and information about various cosmetic products, including insights into their individual components.

DeepSearch

Series B in 2018
DeepSearch, Inc. is a financial research company based in Seoul, South Korea, founded in 2013. It operates a comprehensive research platform designed for individual investors, providing them with essential financial information and analytical tools. The company offers various solutions, including DeepSearch, an online platform that delivers financial data and analysis; SNEK, which aids users in evaluating companies; and DDI Alerts, a service that helps users anticipate risks and make timely decisions to mitigate them. Additionally, DeepSearch features an Index solution that allows users to create customized investment indices, enhancing their investment strategies. The company's goal is to empower individual investors with the tools required for informed decision-making in the financial markets.

Wellmarker Bio

Venture Round in 2018
Wellmarker Bio focuses on developing innovative cancer drugs. Leveraging its expertise in biomarker research and R&D infrastructure from Asan Medical Center, the company aims to create new therapies that overcome drug resistance and address unmet medical needs in various cancers like colon, lung, and liver.

3D MediVision

Series B in 2018
3D MediVision develops, manufactures, and sells 3D visualization and live-casting systems for surgery. Its product line includes 3D and 2D cameras, recorders, monitors, and ultrasound systems, and it offers SURGFLIX, a surgical content-sharing platform, and VeterFlix, a veterinary training platform. The imaging system can be mounted on surgical microscopes to convert the ocular view into a digital, multi-dimensional image that can be streamed or recorded for educational use. The company distributes its products through authorized distributors in India, Spain, Mexico, and China. Founded in 2011, it is based in Seoul, South Korea.

DxGen

Venture Round in 2018
DxGen Corp. is a company specializing in point-of-care diagnostics, focusing on the development of tools for diabetes diagnosis and management. Established in 2016 and headquartered in Gunpo-si, South Korea, with a sales office in San Diego, California, DxGen offers a range of products designed to assist healthcare professionals throughout various stages of diabetes care. Its portfolio includes semi-automatic and fully-automatic analyzers, a magnetic particle separator, and an immune-assay analyzer, all aimed at enhancing clinical decision-making and treatment outcomes for patients. DxGen's innovative solutions facilitate timely assessments and interventions in both diabetes and tuberculosis care.

EnhancedBio

Venture Round in 2018
EnhancedBio Inc. is a biopharmaceutical company based in Seoul, South Korea, that focuses on researching and developing anti-cancer therapeutics. Founded in 2016, the company is dedicated to creating innovative treatments for cancer patients globally. Its product pipeline includes HPV siRNA therapeutics aimed at addressing various cancers linked to Human Papilloma Virus infection. In addition, EnhancedBio is developing small molecular drug candidates targeting other oncological pathways, such as PTEN, PMVK, and RRM2. By concentrating on target-specific drugs and companion diagnostics, EnhancedBio aims to enhance cancer treatment options available to healthcare professionals, ultimately improving patient outcomes.

Parking Cloud

Series B in 2017
Parking Cloud Co., Ltd. is an online platform based in Seoul, South Korea, that provides a comprehensive solution for parking management. Founded in 2009, the company allows customers to check real-time parking availability, compare prices, and make payments through a mobile wallet. Its services extend beyond standard parking, incorporating features such as car sharing, car rental, maintenance, car washing, and electric vehicle charging stations. Parking Cloud also engages in the development, leasing, and operation of parking facilities, including rentals for buses and freight vehicles. The company manufactures parking system devices that facilitate unmanned settlement processes in parking lots. By integrating these services, Parking Cloud aims to streamline the parking experience for users and enhance the management of parking spaces in urban areas.

Xcell Therapeutics

Venture Round in 2017
Xcell Therapeutics Inc. is a biotechnology company focused on the development and production of innovative drugs for cell therapy. Founded in 2015 and based in Seoul, South Korea, the company specializes in creating serum-free chemically defined media, with its flagship product being CellCor. This proprietary medium is designed for the cultivation of human mesenchymal stem cells, facilitating advancements in regenerative medicine and therapeutic applications.

Vuno

Series A in 2016
Vuno Inc. is a South Korean company specializing in the development of artificial intelligence solutions for the medical field. Founded in 2014, Vuno focuses on creating AI-based products that assist healthcare professionals in analyzing medical data and diagnosing diseases. Its notable offerings include BoneAge, which assesses bone age, DeepBrain, designed for the analysis of neurodegenerative diseases, and a chest X-ray diagnostic support system. Additionally, Vuno provides fundus AI for eye abnormalities and LungCT AI for detecting and reporting pulmonary nodules. The company serves a range of clients, including Asan Medical Center and HYUNDAI, and also offers VunoMed, a platform for analyzing various medical data types, including videos, ECGs, and electronic medical records.

Doosan Fuel Cell

Venture Round in 2016
Doosan Fuel Cell Co., Ltd. is a South Korean company that specializes in the development and distribution of power generation fuel cells. Founded in 2019 and headquartered in Iksan-si, the company primarily offers its M400 fuel cell, which generates approximately 440 kW of power and heat. These fuel cells are utilized in various applications, including power plants, refrigerated warehouses, large buildings, and hot springs, as well as in natural gas, LPG, and hydrogen projects. Doosan Fuel Cell is recognized for manufacturing stable and efficient fuel cells that contribute to clean energy solutions.

Kmong

Seed Round in 2015
Kmong Inc. is a South Korean company that operates a freelance and micro-job marketplace, facilitating the exchange of services between individuals. Established in June 2012, the platform allows users to buy and sell a wide range of services across various categories, including design, IT and programming, marketing, consulting, translation, writing, and more. Freelancers can list their services with price quotes, making it easier for potential clients to find and engage with them. Kmong's services extend beyond traditional categories to include offerings like private lessons and unique personal services. The company is based in Seoul and provides a mobile application for Android devices, enhancing accessibility for users.

Chinada

Series A in 2014
Chinada is an education company focused on learning in Chinese. The company’s operations are based in Seoul, Korea.

SolGent

Venture Round in 2014
Solgent Inc., founded in 2000 and based in Daejeon, South Korea, specializes in DNA sequencing and the development of molecular diagnostic kits. The company produces essential raw materials, including DNA polymerase and reagents, which are utilized in genetic assays. Solgent's innovative approach features highly stable versions of Taq polymerase that maintain their effectiveness even after multiple freeze-thaw cycles. This technology enables the production of diagnostic kits that assess the risk of infections, including sexually transmitted diseases, tuberculosis, and influenza, by analyzing genetic information. Through its commitment to advancing molecular diagnostics, Solgent supports healthcare providers in the detection and management of various infectious diseases.

Healcerion

Venture Round in 2013
Healcerion is a Korean company that designs and develops mobile-based healthcare systems to provide physicians and patients with point-of-care diagnostic information. Founded in 2012 and based in Seoul, it has developed the world's first wireless ultrasound system that operates with one hand and transmits ultrasound images to mobile devices via wireless connections, enabling portable, affordable diagnostic capabilities. The company focuses on delivering portable sonography solutions suitable for clinical and remote settings, improving timely diagnosis and patient care through mobile-enabled, easy-to-use imaging technology.

Tripath

Venture Round in 2013
Tripath is a software development company based in Seoul, South Korea, founded in 2011. It specializes in designing and developing web, mobile, server, and application software. The company has created a live chat-based online sales platform that enhances corporate business operations by facilitating real-time interactions between counselors and clients. This platform offers a comprehensive service environment that includes co-browsing and highlighting features, as well as a sales closing module, allowing users to consult while viewing the same screen. By providing an effective online contact point, Tripath aims to help businesses increase their sales volumes and drive revenue growth.

Panax Etec

Venture Round in 2013
Panax Etec is a producer of electrolytes and additives based in Busan, South Korea. The company specializes in creating essential components for the information technology and electric vehicle sectors, particularly focusing on lithium-ion batteries. These electrolytes and additives are utilized in a wide range of portable electronic devices, including cellphones and laptops, supporting the growing demand for efficient and reliable battery performance. Through its innovative products, Panax Etec plays a crucial role in enhancing the functionality and longevity of modern electronic devices.

Aptamer Sciences

Venture Round in 2013
Founded in 2011, Aptamer Sciences specializes in developing innovative therapeutics and diagnostics using its proprietary aptamer technology platform. The company focuses on aptamer discovery, optimization, and application for therapeutic and diagnostic purposes.

L&C BIO Company

Venture Round in 2013
L&C BIO Co., Ltd. is a research and development company specializing in tissue regeneration medicine, headquartered in Seongnam, South Korea. Founded in 2011, the company focuses on improving human health and quality of life through innovative products. L&C BIO develops and provides human tissue, medical devices, and cosmetics, aiming to meet customer needs while maintaining a commitment to quality and service. The company's philosophy emphasizes respect for customers and the delivery of valuable solutions in the healthcare sector.

Ciaat

Venture Round in 2013
CIAAT Co., Ltd., established in 2005 and headquartered in Gwangju, South Korea, specializes in the manufacturing and sale of color ribbons. Its product portfolio includes D2T2 color and panel ribbons in various widths, along with monochrome products, all of which are used in dye sublimation printing technology. The company, formerly known as Digicube Co., Ltd., changed its name to CIAAT Co., Ltd. in 2011.

BioLeaders

Venture Round in 2012
BioLeaders Corporation is a healthcare company based in Yongin, South Korea, founded in 1999. The company focuses on developing innovative medicines, particularly in the field of oncology, with its flagship product being P53, an anti-cancer drug. BioLeaders is advancing several pipeline products, including BLS-H01, currently in phase 3 clinical trials for cervical cancer, and BLS-M07, which has completed phase 2b trials for the same condition. Additionally, the company is working on BLS-M22 for the treatment of Duchenne muscular dystrophy and BLC-H03, a vaccine adjuvant. Beyond pharmaceuticals, BioLeaders also offers health functional foods, raw materials, and functional cosmetic ingredients, positioning itself as a comprehensive provider in the healthcare sector.

AptaBio Therapeutics

Venture Round in 2011
AptaBio Therapeutics Inc. is a pharmaceutical biotechnology company based in Yongin-Si, South Korea, focused on discovering and developing innovative treatments, particularly selective inhibitors of the NOX family of enzymes and aptamer-based anti-cancer drugs. The company offers a range of transfection reagents, including Lipofector-Q, Lipofector-EXT, Lipofector-2000, Lipofector-EZ, and Lipofector-pMAX, designed to facilitate the introduction of DNA or RNA into eukaryotic cells. AptaBio's product pipeline includes several candidates, such as PX-115 for diabetic nephropathy, APX-1004 for diabetic retinopathy, and APX-311 intended for the treatment of non-alcoholic steatohepatitis (NASH). Founded in 2009, AptaBio Therapeutics aims to address significant medical needs through its innovative drug development efforts.

P&H TECH

Venture Round in 2011
P&H Tech Co., Ltd., established in 2009 and based in Yongin, South Korea, specializes in the development, production, and sale of organic light emitting diode (OLED) materials and catalysts. The company's product portfolio includes general OLED materials, electron beam lithography (EBL), hole transport layer (HTL), host materials, OLED intermediates, and palladium (Pd) catalysts. These products are primarily sold to the OLED display market. Additionally, P&H Tech is involved in the manufacturing of chemical materials used in semiconductor production processes.

Krafton

Venture Round in 2009
Krafton Inc is a South Korean video game developer and holding company headquartered in Seongnam. It specializes in creating fantasy games for both PC and mobile platforms, and it is renowned for its popular title, PlayerUnknown's Battlegrounds. In addition to this flagship game, Krafton has developed several other titles, including PUBG: Battlegrounds, PUBG: New State, Tera, Elyon, and Mistover. The company aims to maintain its status as a leading name in the video game industry by adhering to its core value of craftsmanship in game development.

Micro Digital

Venture Round in 2008
Micro Digital is a South Korea-based biotechnology company that specializes in providing advanced systems for the biomedical and environmental industries. The company's product offerings include a Fully Automatic Immuno Analyzer, an Integrated Sample Banking Solution, a Microplate Luminometer, a Nano Spectrophotometer, and a Biomass Desiccation and Pulverization System. Through its innovative technologies, Micro Digital aims to enhance research and diagnostic capabilities in various biomedical applications.

The VIN CSR

Venture Round in 2006
The VIN CSR is a boutique wine company focused on introducing international wines to the South Korean market. The company specializes in importing, manufacturing, retailing, and wholesaling a diverse range of wines, allowing customers in South Korea to access varieties that are not readily available locally. By bridging the gap between international wine producers and South Korean consumers, The VIN CSR enhances the wine selection in the region, catering to both retail and wholesale needs.

AnaPass

Venture Round in 2004
AnaPass specializes in designing and producing system-on-chip semiconductor solutions for display panels worldwide. Its product portfolio includes Timing Controllers for flat panel displays and Mobile Serial Link & Mobile Display Controller ICs for mobile devices.

Payletter

Venture Round in 2003
Payletter Inc. is a company that specializes in online billing and payment services, serving clients across North America, Europe, and Asia. Founded in 2001 and headquartered in Seoul, South Korea, Payletter offers solutions like BillOneQ, which tracks digital content usage, including fixed amounts, time of use, and recurring charges, catering specifically to gaming, PC rooms, and digital products. Additionally, the company provides payoneQ, an integrated payment agent service designed to facilitate secure transactions. Payletter's platform is equipped with advanced security features, such as SSL support and AES encryption, ensuring efficient and secure payment solutions for its users, particularly in the gaming and digital content sectors.

ICTK Co.

Venture Round in 2003
ICTK Co., Ltd. is a South Korean company established in 2001, specializing in payment testing and certification services for mobile devices, payment cards, and point of sale terminals. Headquartered in Seongnam-si, ICTK is an accredited international testing laboratory recognized by major organizations such as EMVCo, Visa, JCB, Discover, Global Platform, NFC Forum, and KOLAS. The company offers advanced engineering services focused on smart cards, mobile devices, and terminals. Additionally, ICTK's Security R&D Division has pioneered developments in Physical Unclonable Functions (PUF)-based security chips and solutions, holding over 80 patents and licenses since 2006. The company is poised to introduce the world's first PUF-based solutions in collaboration with a leading automobile group.

Adbiotech

Venture Round in 2002
ADBiotech Co., Ltd. is a life science company based in Chuncheon-si, South Korea, specializing in the research and development of bio-products for human healthcare, livestock farming, and aquaculture. Founded in 2000, ADBiotech utilizes Immunoglobulin Y (IgY) technology to create orally administered antibodies that serve as alternatives to traditional vaccines and antibiotics. The company also develops functional cosmetics and natural food additives, focusing on health and wellness. Its product offerings include antibiotics, metabolic drugs, anthelmintics, disinfectants, and various feed supplements for livestock. Additionally, ADBiotech is involved in developing specific IgY products aimed at addressing health issues such as cholesterol management and ulcerative colitis. The company collaborates with academic institutions to enhance food safety and expand its product range through innovative research initiatives.

EyeGene

Venture Round in 2002
EyeGene Inc. is a biotechnology company based in Seoul, South Korea, focused on the research and development of biopharmaceutical drugs aimed at treating and preventing age-related diseases. Established in 2000, the company is actively advancing several product candidates through various stages of clinical trials. Its pipeline includes EG-Mirotin, which is in Phase IIa trials for diabetic retinopathy, and EG-HPV, which has completed Phase I trials for cervical cancer. Other notable products include EG-Decorin for pressure ulcers, EG-Myocin for heart muscle treatment, EG-TB for tuberculosis, and EG-HZ, currently in preclinical trials for herpes zoster. EyeGene's commitment to addressing degenerative diseases underscores its role in the biopharmaceutical sector.

SoundGraph

Venture Round in 2002
SoundGraph, Inc. is a digital multimedia company based in Seoul, South Korea, specializing in a variety of audio and video-related products and services. Founded in 2000, the company provides innovative solutions such as FingerUI, a touch interface designed for media playback, and a range of multimedia widgets including weather updates and RSS feeds. SoundGraph also develops SmartPhone products, including speaker docks for iPhones and iPads, home theater PC systems, and USB touch monitors. Additionally, it produces various accessories like mini remote controls. The company markets its products online and through distributors across Asia, North America, and Europe, focusing on enhancing the delivery and management of digital media content for businesses and retail environments.

Mobiis

Venture Round in 2002
Mobiis Co., Ltd. is a South Korean company based in Seongnam that specializes in designing and building equipment and systems for monitoring and controlling particle accelerator beams and related technologies. Founded in 2000, Mobiis offers a range of products, including control systems and equipment such as low-level radio frequency amplifiers, solid-state amplifiers, undulator controllers, and step motor controllers. The company also develops control systems for nuclear fusion reactors, incorporating services like control data access, communication frameworks, central interlock systems, and coil power supply systems. Additionally, Mobiis is involved in computer programming, system integration, and engineering services, providing intelligent control solutions across various sectors.

Avixgen

Venture Round in 2002
Avixgen, Inc. is a drug development company based in Seoul, South Korea, that specializes in creating drugs, therapeutics, and diagnostics for infectious viral diseases. Founded in 2000, Avixgen focuses on formulating innovative therapies and medications aimed at treating conditions such as human immunodeficiency virus infection and acquired immune deficiency syndrome. The company's research and development efforts are dedicated to enhancing human health by providing healthcare providers with new treatment options for these challenging diseases.

Kukdong Corporation

Venture Round in 2001
Kukdong Corporation is a Seoul-based South Korean manufacturer of knit garments for men, women, and children. It produces a broad range of apparel including workwear, activewear, lounge wear, and fashion wear, and it specializes in workwear with functional materials for waterproofing and dustproofing. Founded in 1967, the company serves domestic and international markets, exporting to the United States, the European Union, and Chile while maintaining a presence in global textile supply chains focused on comfort and performance across everyday and specialized garments.

HIMS

Venture Round in 2001
HIMS Co., Ltd., established in 1999 and headquartered in Incheon, South Korea, specializes in the development and sale of inspection modules, display field products, factory automation (FA) equipment, and semiconductor-related items. Its offerings include mask stretchers, mask repair products, mask inspectors, glass AOI products, IR filter inspection systems, blood sugar check sheet inspectors, RVI inspectors, CCFL inspectors, vision modules, and various vision components. Additionally, HIMS deals in Teledyne Delsa frame grabbers, software products, and JAI cameras.

OpenTrade

Venture Round in 2001
Founded in Seoul, South Korea in 2012, OpenTrade operates a platform facilitating communication-based crowdfunding for startups. It enables transparent dialogue between entrepreneurs, investors, and mentors in areas such as management, marketing, and finance.

DiNonA

Venture Round in 2001
DiNonA is a biotechnology company headquartered in Seoul, South Korea. It focuses on the research and development of therapeutic antibodies and diagnostic reagents related to antibodies.
Spot something off? Help us improve by flagging any incorrect or outdated information. Just email us at support@teaserclub.com. Your feedback is most welcome.